- The EU court of justice says a lower court "erred" in some instances in the course of imposing injunctions preventing the EMA from releasing data from clinical trials of AbbVie's (ABBV +0.4%) Humira and from trials conducted by InterMune (ITMN -2.7%).
- The case has been sent back to the EU General Court and, as Reuters notes, the potentially "sensitive data ... will remain under wraps for now."
- The EMA discloses information about clinical studies upon request in an effort to support transparency and satisfy public demand for less secrecy regarding the data.
- Related: Pfizer to broaden access to clinical trial data
EU high court questions injunctions blocking disclosure of trial data
Dec 5 2013, 15:35 ET